Application | Comment | Organism |
---|---|---|
medicine | a 19-bp deletion polymorphism is not associated with overall breast cancer risk, although a borderline significant additive interaction between the dihydrofolate reductase genotype and multivitamin use is observed. Multivitamin supplements may place a subgroup of women, i.e., those with the19-bp allele, at elevated risk of developing breast cancer. A dose-dependent relation between dihydrolfolated reductase expression and the 19 bp deletion genotype is observed | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | 19-base pair deletion polymorphism is not associated with overall breast cancer risk | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |